Roche provided an update on its Phase III SKYSCRAPER-01 study, evaluating tiragolumab in combination with Tecentriq® for ...
SGS has announced the global launch of EDGE Certification, an internationally recognized standard for workplace diversity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback